Eli Lilly’s Omvoh gains FDA approval for treating Crohn’s disease
HQ Team The US Food and Drug Administration (FDA) has approved Eli Lilly’s Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active.
Drugs
Health
Medical
Drugs
Health
Pharma
Eli Lilly to buy Morphic for $3.2 b in cash to expand integrin therapies
Eli Lilly and Company will acquire biopharmaceutical firm, Morphic Holding Inc., for $3.2 billion in cash, giving it access to a molecule inhibitor.
Drugs
Health
Pharma
Bristol’s oral drug to treat Crohn’s disease fails remission test
HQ Team March 29, 2024: Bristol Myers Squibb’s final stage clinical trials for its Zeposia oral drug, to treat moderate to severe Crohn’s.
Drugs
Health
Pharma
Eli Lilly late-stage trial drug for Crohn’s disease meets testing goals
HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.